NCT03178695 - Inovium Ovarian Rejuvenation Trials | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions

Perimenopausal DisorderMenopauseMenopause, PrematureMenopause Related ConditionsMenopause Premature SymptomaticMenopause Premature AsymptomaticPremature Ovarian FailurePremature Ovarian Failure, FamilialPremature Ovarian Failure 2APremature Ovarian Failure 3Premature Ovarian Failure 4Premature Ovarian Failure 1Premature Ovarian Failure 5Premature Ovarian Failure 6Premature Ovarian Failure 7Premature Ovarian Failure 9Premature Ovarian Failure 8InfertilityInfertility, FemaleInfertility Unexplained

Interventions

OTHER

Autologous PRP injection into human ovarian tissue

Using FDA-approved equipment, blood plasma is received from participant, isolated/enriched into PRP, and infused into the ovaries under transvaginal ultrasound guidance.

Trial Locations (1)

92008

Center for Advanced Genetics, Carlsbad